in the Journal of Endocrinology and Metabolism reported AOD 9604 to be well-tolerated across tested doses, with no observed alterations in IGF-1 levels, blood glucose, or insulin sensitivity
Equivalent effects have not been established in people
Challenges and Future Directions While the preliminary results of 5-Amino-1MQ are promising, its essential to acknowledge that the journey from preclinical studies to human applications is complex
Think of AOD 9604 as turning up your metabolic thermostat by a few degrees
This metabolic shift occurs due to the peptides action on the nicotinamide methylation pathway , which increases intracellular NAD+ availability, facilitating greater oxidative metabolism
Monthly costs typically range from $50-150 for research-grade peptide, depending on dosage and source